Overview

Randomized Trial of Continuous Versus Intermittent Cefotaxime Infusion on ICU.

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This study evaluates target attainment after either intermittent intravenous bolus or intravenous continuous infusion of cefotaxime in critically ill patients. Critically ill patients will be randomized to intermittent infusion or continuous infusion of cefotaxime.
Phase:
Phase 4
Details
Lead Sponsor:
University Medical Center Groningen
Treatments:
Cefotaxime
Cefoxitin